Literature DB >> 27161356

How to Manipulate the Microbiota: Fecal Microbiota Transplantation.

Susana Fuentes1, Willem M de Vos2.   

Abstract

Fecal microbiota transplantation (FMT) is a rather straightforward therapy that manipulates the human gastrointestinal (GI) microbiota, by which a healthy donor microbiota is transferred into an existing but disturbed microbial ecosystem. This is a natural process that occurs already at birth; infants are rapidly colonized by a specific microbial community, the composition of which strongly depends on the mode of delivery and which therefore most likely originates from the mother (Palmer et al. 2007; Tannock et al. 1990). Since this early life microbial community already contains most, if not all, of the predominantly anaerobic microbes that are only found in the GI tract, it is reasonable to assume that early life colonization is the ultimate natural fecal transplantation.

Entities:  

Keywords:  Clostridium difficile; Donor; Gastrointestinal microbiota; IBD; Microbial ecology; Regulation; Safety

Mesh:

Year:  2016        PMID: 27161356     DOI: 10.1007/978-3-319-31248-4_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

Review 1.  Evolutionary and ecological forces that shape the bacterial communities of the human gut.

Authors:  J S Messer; E R Liechty; O A Vogel; E B Chang
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

2.  Treatment With Fecal Microbiota Transplantation: The Need for Complete Methodological Reporting for Clinical Trials.

Authors:  Vincent B Young
Journal:  Ann Intern Med       Date:  2017-05-23       Impact factor: 25.391

Review 3.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

Review 4.  The Use of Defined Microbial Communities To Model Host-Microbe Interactions in the Human Gut.

Authors:  Janneke Elzinga; John van der Oost; Willem M de Vos; Hauke Smidt
Journal:  Microbiol Mol Biol Rev       Date:  2019-03-13       Impact factor: 11.056

Review 5.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

Review 6.  Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.

Authors:  Avner Leshem; Nir Horesh; Eran Elinav
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

Review 7.  Effect of the Microbiome on Intestinal Innate Immune Development in Early Life and the Potential Strategy of Early Intervention.

Authors:  Zhipeng Yang; Xiangchen Liu; Yanting Wu; Jian Peng; Hongkui Wei
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

Review 8.  Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases.

Authors:  Yahkub Babatunde Mutalub; Monsurat Abdulwahab; Alkali Mohammed; Aishat Mutalib Yahkub; Sameer Badri Al-Mhanna; Wardah Yusof; Suk Peng Tang; Aida Hanum Ghulam Rasool; Siti Safiah Mokhtar
Journal:  Foods       Date:  2022-08-25

9.  Metabolites Produced by the Oral Commensal Bacterium Corynebacterium durum Extend the Lifespan of Caenorhabditis elegans via SIR-2.1 Overexpression.

Authors:  Jun Hyeong Kim; In Hyuk Bang; Yun Jeong Noh; Dae Keun Kim; Eun Ju Bae; In Hyun Hwang
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.